Table 2. Comparison of Serum and urine component levels in male and female cancer patients.
Parameter | Gender | Before cisplatin treatment | After cisplatin treatment |
Magnesium | Male | 2.03±0.47 | 1.93±0.46 |
Female | 2.15±0.35 | 1.95±0.46* | |
Sodium | Male | 135.61±3.17 | 137.35±3.60* |
Female | 136.98±4.07 | 138.89±5.23 | |
Potassium | Male | 4.24±0.37 | 3.98±0.37 |
Female | 4.44±0.55 | 4.15±0.62* | |
Phosphate | Male | 4.34±0.39 | 3.56±1.04 |
Female | 4.29±0.48 | 3.66±0.85* | |
Calcium | Male | 9.00±0.49 | 8.58±0.61* |
Female | 9.18±0.86 | 8.55±0.82* | |
Chlorine | Male | 96.6±3.94 | 99.01±3.87* |
Female | 100.38±3.02 | 102.89±7.00 | |
Creatinine | Male | 0.80±0.08 | 1.10±0.21* |
Female | 0.77±0.19 | 1.16±0.13* | |
BUN | Male | 10.16±3.91 | 12.81±3.98 |
Female | 13.98±2.98 | 13.78±2.44 |